Capstone Therapeutics Corp. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €38.66M -7.2% -€2.21M -32.9% -5.7% +0.022 pp €3.40M +137.8% 8.8% +0.054 pp
    €41.66M -21.5% -€3.29M -265.0% -7.9% -0.12 pp €1.43M -161.0% 3.4% +0.078 pp
    €53.04M -7.8% €1.99M -41.0% 3.8% -0.021 pp -€2.34M -155.5% -4.4% -0.12 pp
    €57.50M +46.8% €3.38M -62.5% 5.9% -0.17 pp €4.22M +659.2% 7.3% +0.059 pp
    €39.16M +∞% €9.01M -604.3% 23.0% +0.23 pp €555.70K -138.4% 1.4% +0.014 pp
    €0.00 +NaN% -€1.79M +445.5% N/A -€1.45M -2,643.9% N/A
    €0.00 +NaN% -€327.39K -78.3% N/A €56.86K -104.2% N/A
    €0.00 +NaN% -€1.51M +164.7% N/A -€1.34M +29.1% N/A
    €0.00 +NaN% -€571.21K -76.1% N/A -€1.04M -43.8% N/A
    €0.00 +NaN% -€2.39M -33.5% N/A -€1.85M -47.4% N/A
    €0.00 +NaN% -€3.59M +6.3% N/A -€3.53M +3.6% N/A
    €0.00 -€3.38M N/A -€3.40M N/A

    Notifications